Search results
Why Novavax Stock More Than Doubled Today
Motley Fool via Yahoo Finance· 2 weeks agoShares of Novavax (NASDAQ: NVAX) are up 12% as of midday Friday following the release of the drugmaker's first-quarter results. It's not the report,...
3 Things You Need to Know If You Buy Novavax Today
Motley Fool via Yahoo Finance· 2 days agoNovavax (NASDAQ: NVAX) stock has both soared and plummeted at times in recent years. Investors initially bet on the biotech company to be a winner in the...
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Motley Fool via Yahoo Finance· 4 months agoNovavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability...
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 1 week agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NASDAQ: NVAX) stock has finally taken off. The biotech soared 190% in two...
Novavax (NVAX) Q4 Earnings & Revenues Miss Estimates, Stock Down
Zacks via Yahoo Finance· 1 year agoNovavax (NVAX) reports worse-than-expected financial performance in the fourth quarter of 2022, with...
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use
Zacks via Yahoo Finance· 6 months agoNovavax NVAX announced that the World Health Organization (“WHO”) has granted emergency use listing...
Will Novavax's Covid Booster Thesis Play Out? What The Survey Says
Investor's Business Daily· 2 years agoNovavax's Covid booster is preemptively gaining steam, according to the July IBD/TIPP Poll. The...
FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines
CBS News via Yahoo News· 2 years agoThe Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...
Could Novavax Stock Help You Become a Millionaire?
Motley Fool via Yahoo Finance· 4 months agoNovavax (NASDAQ: NVAX) stock may have made some millionaires back in 2020. It was the height of the coronavirus vaccine race, and investors were betting...
IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine
Investor's Business Daily· 2 years agoNovavax could struggle to find a U.S. market for its Covid vaccine, according to the latest IBD/TIPP...
